Aviva
SRCL

Aviva’s Stericycle Inc SRCL Stock Holding History

Aviva’s Portfolio SRCL Stock Details SRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-84,416
Closed -$4.03M – 811
2019
Q2 		$4.03M Sell
84,416
-144
-0.2% -$7.33K 0.03% 512
2019
Q1 		$4.6M Sell
84,560
-31,354
-27% -$1.42M 0.03% 482
2018
Q4 		$4.25M Sell
115,914
-26,369
-19% -$1.24M 0.03% 473
2018
Q3 		$8.35M Buy
142,283
+14,062
+11% +$898K 0.05% 374
2018
Q2 		$8.37M Sell
128,221
-1,812
-1% -$113K 0.05% 358
2018
Q1 		$7.61M Sell
130,033
-4,147
-3% -$281K 0.05% 376
2017
Q4 		$9.12M Buy
134,180
+365
+0.3% +$24.8K 0.05% 351
2017
Q3 		$9.58M Buy
133,815
+4,128
+3% +$304K 0.05% 359
2017
Q2 		$9.9M Buy
129,687
+220
+0.2% +$18.1K 0.06% 356
2017
Q1 		$10.7M Sell
129,467
-2,946
-2% -$237K 0.06% 326
2016
Q4 		$10.2M Buy
132,413
+3,218
+2% +$243K 0.06% 328
2016
Q3 		$10.4M Buy
129,195
+3,731
+3% +$337K 0.06% 330
2016
Q2 		$13.1M Buy
125,464
+7,104
+6% +$760K 0.09% 260
2016
Q1 		$14.9M Buy
118,360
+30,233
+34% +$3.52M 0.11% 198
2015
Q4 		$10.6M Buy
88,127
+48,270
+121% +$6.15M 0.08% 272
2015
Q3 		$5.55M Sell
39,857
-757
-2% -$105K 0.05% 431
2015
Q2 		$5.44M Sell
40,614
-2,700
-6% -$370K 0.04% 473
2015
Q1 		$6.08M Buy
43,314
+9,873
+30% +$1.33M 0.04% 470
2014
Q4 		$4.38M Sell
33,441
-170
-0.5% -$21.4K 0.03% 515
2014
Q3 		$3.92M Sell
33,611
-100
-0.3% -$11.8K 0.03% 556
2014
Q2 		$3.99M Sell
33,711
-370
-1% -$42.3K 0.03% 552
2014
Q1 		$3.87M Buy
34,081
+1,720
+5% +$199K 0.03% 540
2013
Q4 		$3.76M Buy
32,361
+11,739
+57% +$1.37M 0.03% 536
2013
Q3 		$2.38M Buy
20,622
+6,249
+43% +$721K 0.02% 647
2013
Q2 		$1.59M Buy
+14,373
New +$1.56M 0.02% 666

Other funds holding SRCL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Aviva's SRCL Position: Q3 2019 in Review

Aviva sold out of Stericycle Inc (SRCL) in Q3 2019, closing a stake of 84,416 shares — an estimated $4.03M sold.

Aviva first reported a position in SRCL in Q2 2013 and held it in 25 quarters. The position peaked at $14.9M in Q1 2016. 351 funds tracked by Wall St. Rank hold SRCL as of Q3 2019.

  • Aviva reported no remaining Stericycle Inc position as of Q3 2019 after selling out during the quarter.
  • Aviva sold 84,416 Stericycle Inc shares in Q3 2019, an estimated $4.03M.
  • Aviva first reported a position in Stericycle Inc in Q2 2013 and held it in 25 quarters.
  • Aviva's Stericycle Inc position peaked at $14.9M in Q1 2016.
  • 351 funds tracked by Wall St. Rank held Stericycle Inc as of Q3 2019.

Based on Aviva's 13F filing for Q3 2019, filed 12 Nov 2019.